AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹4.93 Cr | ₹5.68 Cr | ₹11 Cr | ₹47 Cr | ₹29 Cr |
What is the latest Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹4.93 Cr |
Mar2024 | ₹5.68 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹47 Cr |
Mar2021 | ₹29 Cr |
How is Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹4.93 Cr | -13.20 | |
Mar2024 | ₹5.68 Cr | -50.37 | |
Mar2023 | ₹11 Cr | -75.76 | |
Mar2022 | ₹47 Cr | 60.86 | |
Mar2021 | ₹29 Cr | - |
Compare Consolidated Net Profit of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹248.1 Cr | -6.4% | -11.7% | -53.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,500.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -6.4% |
-11.7% |
-53.1% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses